- Home
- MRVI vs TWN Comparison
MRVI vs TWN Comparison
Compare MRVI & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- TWN
- Stock Information
- Founded
- MRVI 2014
- TWN 1986
- Country
- MRVI United States
- TWN Hong Kong
- Employees
- MRVI N/A
- TWN N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- MRVI Health Care
- TWN Finance
- Exchange
- MRVI Nasdaq
- TWN Nasdaq
- Market Cap
- MRVI 376.2M
- TWN 346.7M
- IPO Year
- MRVI 2020
- TWN N/A
- Fundamental
- Price
- MRVI $3.34
- TWN $55.00
- Analyst Decision
- MRVI Hold
- TWN
- Analyst Count
- MRVI 9
- TWN 0
- Target Price
- MRVI $4.54
- TWN N/A
- AVG Volume (30 Days)
- MRVI 1.4M
- TWN 20.1K
- Earning Date
- MRVI 11-06-2025
- TWN 01-01-0001
- Dividend Yield
- MRVI N/A
- TWN 1.10%
- EPS Growth
- MRVI N/A
- TWN N/A
- EPS
- MRVI N/A
- TWN N/A
- Revenue
- MRVI $219,830,000.00
- TWN N/A
- Revenue This Year
- MRVI N/A
- TWN N/A
- Revenue Next Year
- MRVI $7.23
- TWN N/A
- P/E Ratio
- MRVI N/A
- TWN N/A
- Revenue Growth
- MRVI N/A
- TWN N/A
- 52 Week Low
- MRVI $1.67
- TWN $25.22
- 52 Week High
- MRVI $8.54
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- MRVI 69.44
- TWN 66.22
- Support Level
- MRVI $2.94
- TWN $54.22
- Resistance Level
- MRVI $3.30
- TWN $57.01
- Average True Range (ATR)
- MRVI 0.20
- TWN 1.60
- MACD
- MRVI 0.04
- TWN -0.12
- Stochastic Oscillator
- MRVI 91.98
- TWN 64.37
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.